EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Bacteriophage therapy for multidrug-resistant infections: current technologies and therapeutic approaches

Minyoung Kevin Kim, Gina A Suh, Grace D Cullen, Saumel Perez Rodriguez, Tejas Dharmaraj, Tony Hong Wei Chang, Zhiwei Li, Qingquan Chen, Sabrina I Green, Rob Lavigne, Jean-Paul Pirnay, Paul L Bollyky und 1 weitere

Journal of Clinical Investigation · 03.03.2025 · 135 (5)

DOI: 10.1172/jci187996 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Investigation, online erschienen am 03.03.2025. Verfasst von Minyoung Kevin Kim und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University, Stanford, California, USA. Hauptthemen laut MEDLINE: Phage Therapy, Drug Resistance, Multiple, Bacterial, Bacteriophages, Bacterial Infections. Die Arbeit wurde bisher 116-mal zitiert (Crossref) und nennt 212 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIBIB NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacteriophage (phage) therapy has emerged as a promising solution to combat the growing crisis of multidrug-resistant (MDR) infections. There are several international centers actively engaged in implementation of phage therapy, and recent case series have reported encouraging success rates in patients receiving personalized, compassionate phage therapy for difficult-to-treat infections. Nonetheless, substantial hurdles remain in the way of more widespread adoption and more consistent success. This Review offers a comprehensive overview of current phage therapy technologies and therapeutic approaches. We first delineate the common steps in phage therapy development, from phage bank establishment to clinical administration, and examine the spectrum of therapeutic approaches, from personalized to fixed phage cocktails. Using the framework of a conventional drug development pipeline, we then identify critical knowledge gaps in areas such as cocktail design, formulation, pharmacology, and clinical trial design. We conclude that, while phage therapy holds promise, a structured drug development pipeline and sustained government support are crucial for widespread adoption of phage therapy for MDR infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phage TherapyDrug Resistance, Multiple, BacterialBacteriophagesBacterial InfectionsHumansAnimals

Autor:innen und Institutionen

  • Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University, Stanford, California, USA.
  • Department of Medicine, Yale University, New Haven, Connecticut, USA.
  • Division of Public Health, Infectious Diseases and Occupational Health, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
  • Laboratory of Gene Technology, Department of Biosystems, KU Leuven, Leuven, Belgium.
  • Laboratory for Molecular and Cellular Technology, Queen Astrid Military Hospital, Brussels, Belgium.
  • Phage Directory, Atlanta, Georgia, USA.

Förderung

  • NIAID NIH HHS
  • NIBIB NIH HHS
  • NHLBI NIH HHS

Zitieren

APA

Kim, M. K., Suh, G. A., Cullen, G. D., Perez Rodriguez, S., Dharmaraj, T., Chang, T. H. W., Li, Z., Chen, Q., Green, S. I., Lavigne, R., Pirnay, J. P., Bollyky, P. L., & Sacher, J. C. (2025). Bacteriophage therapy for multidrug-resistant infections: current technologies and therapeutic approaches. Journal of Clinical Investigation, 135(5). https://doi.org/10.1172/jci187996

Vancouver

Kim MK, Suh GA, Cullen GD, Perez Rodriguez S, Dharmaraj T, Chang THW, et al. Bacteriophage therapy for multidrug-resistant infections: current technologies and therapeutic approaches. Journal of Clinical Investigation. 2025;135(5). doi:10.1172/jci187996

BibTeX
@article{Kim2025,
  author = {Kim, Minyoung Kevin and Suh, Gina A and Cullen, Grace D and Perez Rodriguez, Saumel and Dharmaraj, Tejas and Chang, Tony Hong Wei and Li, Zhiwei and Chen, Qingquan and Green, Sabrina I and Lavigne, Rob and Pirnay, Jean-Paul and Bollyky, Paul L and Sacher, Jessica C},
  title = {Bacteriophage therapy for multidrug-resistant infections: current technologies and therapeutic approaches},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  volume = {135},
  number = {5},
  doi = {10.1172/jci187996}
}
Kostenlos starten →